Article info
Letter
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritis
- Correspondence to Professor Georg Schett, Rheumatology, Friedrich-Alexander-Universitat Erlangen-Nurnberg, Erlangen, Bayern, Germany; georg.schett{at}uk-erlangen.de
Citation
Sequential interleukin-17/interleukin-23 inhibition in treatment-refractory psoriatic arthritis
Publication history
- Received March 15, 2022
- Accepted April 25, 2022
- First published May 5, 2022.
Online issue publication
August 11, 2022
Article Versions
- Previous version (5 May 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.